Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus

Objective. To evaluate the association between anti-phosphatidylethanolamine (aPE) and anti-phosphatidylserine (aPS) antibodies and cardiovascular risk, organ involvement and disease activity in systemic lupus erythematosus (SLE) patients. Methods. We studied 93 SLE patients and 30 controls. We anal...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Biomolecules
المؤلفون الرئيسيون:	Katarzyna Fischer, Hanna Przepiera-Będzak, Iwona Brzosko, Marcin Sawicki, Anna Walecka, Marek Brzosko
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-09-01
الموضوعات:	anti-phosphatidylethanolamine antibodies anti-phosphatidylserine antibodies systemic lupus erythematosus antiphospholipid syndrome renal involvement cardiovascular risk
الوصول للمادة أونلاين:	https://www.mdpi.com/2218-273X/12/10/1328